LINASUG-DM 500 - Lingaliptin 5mg+Dapagliflozin 10mg+ Metformin Hcl (SR) 500mg/1000mg | Intralife Pharmaceuticals
DIASAGE
Premium

LINASUG-DM 500

MRP: 2

Packaging: 10x10

Pack Type: tablet

Composition:

Lingaliptin 5mg+Dapagliflozin 10mg+ Metformin Hcl (SR) 500mg/1000mg

Indication:

Reduces the hepatic glucose uptake by 19%.

Description:

Linagliptin 5mg + Dapagliflozin 10mg + Metformin Hydrochloride (SR) 500mg/1000mg is a potent triple oral antidiabetic combination formulated for effective management of type 2 diabetes mellitus. This fixed-dose combination targets blood glucose control through three complementary mechanisms:

  • Linagliptin (5mg): A DPP-4 inhibitor that enhances incretin hormones, promoting insulin release and suppressing glucagon secretion to reduce blood sugar, especially post-meal.

  • Dapagliflozin (10mg): An SGLT2 inhibitor that helps lower blood glucose by increasing urinary glucose excretion, also aiding weight loss and improving cardiovascular health.

  • Metformin Hydrochloride (SR) (500mg or 1000mg): A biguanide with sustained release that reduces hepatic glucose production and improves insulin sensitivity, providing long-lasting blood sugar control.

This combination effectively reduces fasting and postprandial glucose levels, improves HbA1c, supports weight management, and lowers cardiovascular risks associated with diabetes.

Tags:

Anti-diabetic Type 2 Diabetes Triple Combination DPP-4 Inhibitor SGLT2 Inhibitor Biguanide Sustained Release Oral Tablet Blood Sugar Control Cardiovascular Benefits
  • Controls fasting and postprandial blood glucose effectively
  • Supports weight loss and reduces cardiovascular risks
  • Sustained release Metformin reduces gastrointestinal side effects
  • Improves insulin secretion and sensitivity
  • Convenient once-daily oral dosing
  • Helps reduce HbA1c and complications related to diabetes

Usage Information

Dosage

Take one tablet once daily with food, or as directed by your healthcare provider Swallow the tablet whole; do not crush or chew Maintain consistent meal times to minimize hypoglycemia risk

Side Effects

Hypoglycemia (low blood sugar) Genital infections or urinary tract infections (due to Dapagliflozin) Gastrointestinal discomfort (nausea, diarrhea, bloating) Headache Rare: dehydration, hypotension, or lactic acidosis (Metformin)

Contraindications

Allergy to Linagliptin, Dapagliflozin, or Metformin Type 1 diabetes or diabetic ketoacidosis Severe renal or hepatic impairment History of lactic acidosis Pregnancy and breastfeeding without medical advice Recurrent urinary tract or genital infections

Availability

Linagliptin Dapagliflozin Metformin triple combo Dapagliflozin 10mg Linagliptin 5mg Metformin SR Type 2 diabetes oral triple therapy SGLT2 inhibitor with DPP-4 and Metformin Blood sugar control combination tablet Diabetes medicine with weight loss benefits Metformin sustained release combination Oral antidiabetic triple drug therapy Cardiovascular benefits in diabetes treatment Effective type 2 diabetes management tablet

Linagliptin + Dapagliflozin + Metformin SR Triple Combo for Diabetes | Intralife Pharmaceuticals | Intralife